APO Research
Talk to an analyst

APO RESEARCH · REPORT

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Growth and Trends Forecast to 2032

22 December 2025101 pages

Choose your research edition.

Industry ResearchOrthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Research Report 2026127 pages · $2,950 USDIndustry Growth & TrendsGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) include Merck, Roche, GSK, Bayer, Sunstar, Showa Yakuhin Kako, Septodont, PerioChip and JandJ, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Company

Merck

Roche

GSK

Bayer

Sunstar

Showa Yakuhin Kako

Septodont

PerioChip

JandJ

DenMat

Colgate-Palmolive

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Type

Injection Type

Oral Type

Others

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Application

Hospital

Clinic

Others

Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Type Table 2. Major Company of Oral Type Table 3. Major Company of Others Table 4. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 6. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type (2021-2026) Table 7. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 8. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type (2021-2026) Table 9. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price by Type (2021-2026) & (US$/unit) Table 10. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2027-2032) & (k units) Table 11. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type (2027-2032) Table 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2027-2032) & (US$ Million) Table 13. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type (2027-2032) Table 14. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price by Type (2027-2032) & (US$/unit) Table 15. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 16. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 18. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 20. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 22. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (k units) Table 24. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Type (2021-2026) & (US$ Million) Table 25. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends Table 26. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Drivers Table 27. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Opportunities and Challenges Table 28. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Restraints Table 29. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue Market Share by Company (2021-2026) Table 31. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Company (2021-2026) & (k units) Table 32. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Company (2021-2026) Table 33. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Price by Company (2021-2026) & (US$/unit) Table 34. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Company Production Sites and Headquarters Table 36. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Company, Product Type & Application Table 37. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2021-2026) & (k units) Table 42. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Region (2021-2026) Table 43. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2021-2026) & (US$ Million) Table 44. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Region (2021-2026) Table 45. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2027-2032) & (k units) Table 47. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Region (2027-2032) Table 48. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Region (2027-2032) & (US$ Million) Table 49. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Region (2027-2032) Table 50. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 51. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 53. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application (2021-2026) Table 54. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 55. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application (2021-2026) Table 56. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price by Application (2021-2026) & (US$/unit) Table 57. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2027-2032) & (k units) Table 58. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application (2027-2032) Table 59. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2027-2032) & (US$ Million) Table 60. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application (2027-2032) Table 61. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price by Application (2027-2032) & (US$/unit) Table 62. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 63. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 65. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 67. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 69. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (k units) Table 71. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Application (2021-2026) & (US$ Million) Table 72. Merck Company Information Table 73. Merck Business Overview Table 74. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 76. Merck Recent Development Table 77. Roche Company Information Table 78. Roche Business Overview Table 79. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 81. Roche Recent Development Table 82. GSK Company Information Table 83. GSK Business Overview Table 84. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 86. GSK Recent Development Table 87. Bayer Company Information Table 88. Bayer Business Overview Table 89. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 91. Bayer Recent Development Table 92. Sunstar Company Information Table 93. Sunstar Business Overview Table 94. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 96. Sunstar Recent Development Table 97. Showa Yakuhin Kako Company Information Table 98. Showa Yakuhin Kako Business Overview Table 99. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 101. Showa Yakuhin Kako Recent Development Table 102. Septodont Company Information Table 103. Septodont Business Overview Table 104. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 106. Septodont Recent Development Table 107. PerioChip Company Information Table 108. PerioChip Business Overview Table 109. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 111. PerioChip Recent Development Table 112. JandJ Company Information Table 113. JandJ Business Overview Table 114. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 116. JandJ Recent Development Table 117. DenMat Company Information Table 118. DenMat Business Overview Table 119. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 120. DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 121. DenMat Recent Development Table 122. Colgate-Palmolive Company Information Table 123. Colgate-Palmolive Business Overview Table 124. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 125. Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio Table 126. Colgate-Palmolive Recent Development Table 127. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 128. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 129. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2026) Table 130. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032) & (k units) Table 131. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Country (2027-2032) Table 132. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 133. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026) & (US$ Million) Table 134. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2021-2026) Table 135. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 136. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Country (2027-2032) Table 137. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 138. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 139. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2026) Table 140. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032) & (k units) Table 141. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Country (2027-2032) Table 142. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 143. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026) & (US$ Million) Table 144. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2021-2026) Table 145. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 146. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 149. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2026) Table 150. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032) & (k units) Table 151. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Country (2027-2032) Table 152. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 153. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026) & (US$ Million) Table 154. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2021-2026) Table 155. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 156. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Country (2027-2032) Table 157. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 158. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 159. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2026) Table 160. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032) & (k units) Table 161. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Country (2027-2032) Table 162. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 163. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026) & (US$ Million) Table 164. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2021-2026) Table 165. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 166. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026) & (k units) Table 169. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share by Country (2021-2026) Table 170. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032) & (k units) Table 171. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share Forecast by Country (2027-2032) Table 172. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 173. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026) & (US$ Million) Table 174. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country (2021-2026) Table 175. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032) & (US$ Million) Table 176. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share Forecast by Country (2027-2032) Table 177. Key Raw Materials Table 178. Raw Materials Key Suppliers Table 179. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors List Table 180. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customers List Table 181. Research Programs/Design for This Report Table 182. Authors List of This Report Table 183. Secondary Sources Table 184. Primary Sources List of Figures Figure 1. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Image Figure 2. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size (2021-2032) & (US$ Million) Figure 4. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2021-2032) & (k units) Figure 5. Injection Type Image Figure 6. Global Injection Type Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Type Image Figure 8. Global Oral Type Sales YoY Growth (2021-2032) & (k units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 11. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Type 2025 VS 2032 Figure 13. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type in 2025 Figure 14. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type in 2025 Figure 15. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type in 2025 Figure 16. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type in 2025 Figure 19. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Hospital Image Figure 26. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 27. Clinic Image Figure 28. Global Clinic Sales YoY Growth (2021-2032) & (k units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Application 2025 VS 2032 Figure 33. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application in 2025 Figure 34. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application in 2025 Figure 35. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application in 2025 Figure 36. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application in 2025 Figure 39. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Market Share in Value by Application in 2025 Figure 43. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Type
  • Oral Type
  • Others
Applications
  • Hospital
  • Clinic
  • Others
Companies covered
  • Merck
  • Roche
  • GSK
  • Bayer
  • Sunstar
  • Showa Yakuhin Kako
  • Septodont
  • PerioChip
  • JandJ
  • DenMat
  • Colgate-Palmolive

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Type
  6. 1.3.1 Injection Type
  7. 1.3.2 Oral Type
  8. 1.3.3 Others
  9. 1.4 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Type
  10. 1.4.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Trends
  2. 2.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Drivers
  3. 2.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Opportunities and Challenges
  4. 2.4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Revenue (2021-2026)
  2. 3.2 Global Top Players by Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (2021-2026)
  3. 3.3 Global Top Players by Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Price (2021-2026)
  4. 3.4 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Major Company Production Sites & Headquarters
  6. 3.6 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Company, Product Type & Application
  7. 3.7 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Tier 1, Tier 2, and Tier 3
4 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Regional Status and Outlook
  1. 4.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size by Region
  3. 4.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Region
  7. 4.3.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) by Application
  1. 5.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Others
  5. 5.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Application
  6. 5.2.1 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Merck
  2. 6.1.1 Merck Company Information
  3. 6.1.2 Merck Business Overview
  4. 6.1.3 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Merck Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  6. 6.1.5 Merck Recent Developments
  7. 6.2 Roche
  8. 6.2.1 Roche Company Information
  9. 6.2.2 Roche Business Overview
  10. 6.2.3 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Roche Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  12. 6.2.5 Roche Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Sunstar
  26. 6.5.1 Sunstar Company Information
  27. 6.5.2 Sunstar Business Overview
  28. 6.5.3 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Sunstar Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  30. 6.5.5 Sunstar Recent Developments
  31. 6.6 Showa Yakuhin Kako
  32. 6.6.1 Showa Yakuhin Kako Company Information
  33. 6.6.2 Showa Yakuhin Kako Business Overview
  34. 6.6.3 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Showa Yakuhin Kako Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  36. 6.6.5 Showa Yakuhin Kako Recent Developments
  37. 6.7 Septodont
  38. 6.7.1 Septodont Company Information
  39. 6.7.2 Septodont Business Overview
  40. 6.7.3 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Septodont Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  42. 6.7.5 Septodont Recent Developments
  43. 6.8 PerioChip
  44. 6.8.1 PerioChip Company Information
  45. 6.8.2 PerioChip Business Overview
  46. 6.8.3 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 PerioChip Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  48. 6.8.5 PerioChip Recent Developments
  49. 6.9 JandJ
  50. 6.9.1 JandJ Company Information
  51. 6.9.2 JandJ Business Overview
  52. 6.9.3 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 JandJ Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  54. 6.9.5 JandJ Recent Developments
  55. 6.10 DenMat
  56. 6.10.1 DenMat Company Information
  57. 6.10.2 DenMat Business Overview
  58. 6.10.3 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 DenMat Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  60. 6.10.5 DenMat Recent Developments
  61. 6.11 Colgate-Palmolive
  62. 6.11.1 Colgate-Palmolive Company Information
  63. 6.11.2 Colgate-Palmolive Business Overview
  64. 6.11.3 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Colgate-Palmolive Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Product Portfolio
  66. 6.11.5 Colgate-Palmolive Recent Developments
7 North America by Country
  1. 7.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
  2. 7.1.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026)
  4. 7.1.3 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032)
  5. 7.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
  6. 7.2.1 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026)
  8. 7.2.3 North America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
  2. 8.1.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026)
  4. 8.1.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
  6. 8.2.1 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026)
  8. 8.2.3 Europe Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
  2. 9.1.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
  6. 9.2.1 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
  2. 10.1.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026)
  4. 10.1.3 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032)
  5. 10.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
  6. 10.2.1 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026)
  8. 10.2.3 South America Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country
  2. 11.1.1 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country
  6. 11.2.1 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Value Chain Analysis
  2. 12.1.1 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Production Mode & Process
  7. 12.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Distributors
  10. 12.2.3 Orthopedics Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst